Ought doctors to take drug costs into account when they advice advanced cancer patients? Peter Bach at Memorial Sloan Kettering reacts in this phone interview to a cost-conscious commentary “How Much is Life Worth?” in JNCI (Journal of the National Institute).

Listen to the podcast at JNCI

(You’ll need the QuickTime plug-in installed in your browser. It’s safe and free to download. Follow your browser’s instructions).

The article discussed is How Much Is Life Worth: Cetuximab, Non–Small Cell Lung Cancer, and the $440 Billion Question by Tito Fojo, Christine Grady, appeared June 29 2009.

This interview is a JNCI podcast.